« Previous
Next »
Early Human Development
Volume 86, Issue 4
, Pages 197-201
, April 2010
Circulating adipocyte fatty acid binding protein levels in healthy preterm infants: Positive correlation with weight gain and total-cholesterol levels
References
- . Fatty acid binding proteins—the evolutionary crossroads of inflammatory and metabolic responses. J Nutr. 2004;134:S2464–S2468
- . Cytoplasmic fatty acid-binding proteins: emerging roles in metabolism and atherosclerosis. Curr Opin Lipidol. 2002;13:141–147
- . The multigene family of fatty acid-binding proteins (FABPs): function, structure and polymorphism. J Appl Genet. 2006;47:39–48
- . Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice. J Clin Invest. 2008;118:2640–2650
- . Improved glucose and lipid metabolism in genetically obese mice lacking aP2. Endocrinology. 2000;141:3388–3396
- . Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science. 1996;274:1377–1379
- . Targeted disruption of the adipocyte lipid-binding protein (aP2 protein) gene impairs fat cell lipolysis and increases cellular fatty acid levels. J Lipid Res. 1999;40:967–972
- Altered insulin secretion with reduced lipolytic efficiency in aP2−/− mice. Diabetes. 1999;48:1987–1994
- Investigation of in vivo fatty acid metabolism in AFABP/aP2(−/−) mice. Am J Physiol Endocrinol Metab. 2005;288:E187–E193
- . The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor γ and IκB kinase activities. J Biol Chem. 2005;280:12888–12895
- Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat Med. 2001;7:699–705
- Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature. 2007;447:959–965
- Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin Chem. 2006;52:405–413
- Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome. A 5-year prospective study. Circulation. 2007;115:1537–1543
- . The impact of early nutrition in premature infants on later childhood insulin sensitivity and growth. Pediatrics. 2006;118:1943–1949
- . Prematurity—another example of perinatal metabolic programming?. Horm Res. 2006;66:33–39
- Premature birth and later insulin resistance. N Engl J Med. 2004;351:2179–2186
- Influence of prematurity and growth restriction on the adipokine profile, IGF1, and ghrelin levels in cord blood: relationship with glucose metabolism. Eur J Endocrinol. 2009;161:381–389
- . Adiponectin, an adipocyte-derived protein, predicts future insulin resistance: two-year follow-up study in Japanese population. J Clin Endocrinol Metab. 2004;89:87–90
- Circulating leptin levels predict the development of metabolic syndrome in middle-aged men: an 8-year follow-up study. J Hypertens. 2007;25:1671–1677
- . Intracranial hemorrhage: germinal matrix-intraventricular hemorrhage of the premature infant. In: Volpe JJ editors. Neurology of the newborn. Philadelphia: WB Saunders; 2001;p. 428–493
- . New Ballard Score, expanded to include extremely premature infants. J Pediatr. 1991;119:417–423
- . A nearly continuous measure of birth weight for gestational age using a United States national reference. BMC Pediatr. 2003;3:6
- . Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419
- . Adipocyte fatty acid-binding protein in obese children before and after weight loss. Metabolism. 2007;56:1735–1741
- . The increase of fatty acid-binding protein aP2 in overweight and obese children: interactions with dietary fat and impact on measures of subclinical inflammation. Int J Obes (Lond). 2008;32:1513–1520
- Serum concentrations of adipocyte fatty acid binding protein in patients with anorexia nervosa. Physiol Res. 2009;58:577–581
- Plasma fatty acid binding protein 4 is associated with atherogenic dyslipidemia in diabetes. J Lipid Res. 2008;49:1746–1751
- . Hyperadiponectinemia in newborns: relationship with leptin levels and birth weight. Obes Res. 2004;12:521–524
- . Plasma adiponectin levels in newborns are higher than those in adults and positively correlated with birth weight. Clin Endocrinol. 2004;61:418–423
- . Lipid metabolism in the fetus and the newborn. Diabetes Metab Res Rev. 2000;16:202–210
- . Altered adiposity after extremely preterm birth. Pediatr Res. 2005;57:211–215
- . Fatty acid regulation of gene expression. Transcriptional and post-transcriptional mechanisms. J Biol Chem. 1992;267:5937–5941
- A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease. Proc Natl Acad Sci U S A. 2006;103:6970–6975
- Absence of adipocyte fatty acid binding protein prevents the development of accelerated atherosclerosis in hypercholesterolemic mice. FASEB J. 2001;15:1774–1776
- . Adipocyte fatty acid binding protein in a Caucasian population: a new marker of metabolic syndrome?. Eur J Clin Invest. 2006;36:621–625
- . Association between adipocyte fatty acid-binding protein levels and childhood obesity in Korean children. Metabolism. 2009;58:798–802
- Cord plasma concentrations of adiponectin and leptin in healthy term neonates: positive correlation with birthweight and neonatal adiposity. Clin Endocrinol. 2004;61:88–93
- Adiponectin in human cord blood: relation to fetal birth weight and gender. J Clin Endocrinol Metab. 2003;88:5656–5660
- . Circulating levels of adiponectin in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2007;92:F286–F290
- . Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. Eur J Endocrinol. 2002;147:173–180
- . Low nutrient intake and early growth for later insulin resistance in adolescents born preterm. Lancet. 2003;361:1089–1097
PII: S0378-3782(10)00052-6
doi: 10.1016/j.earlhumdev.2010.02.008
© 2010 Elsevier Ireland Ltd. All rights reserved.
« Previous
Next »
Early Human Development
Volume 86, Issue 4
, Pages 197-201
, April 2010
